Jiachang Chi
- Oncology top 10%
- Hepatology top 5%
- Surgery
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (16 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers)Lung Cancer Diagnosis and Treatment (6 papers)
- Cited by
- HepatologyOncologyImmunology
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jiachang Chi
46 papers receiving 936 citations
Peers
Comparison fields: 5 of 68
- Oncology 357
- Hepatology 277
- Surgery 261
- Pulmonary and Respiratory Medicine 227
- Immunology 182
Countries citing papers authored by Jiachang Chi
This map shows the geographic impact of Jiachang Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiachang Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiachang Chi more than expected).
Fields of papers citing papers by Jiachang Chi
This network shows the impact of papers produced by Jiachang Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiachang Chi. The network helps show where Jiachang Chi may publish in the future.
Co-authorship network of co-authors of Jiachang Chi
This figure shows the co-authorship network connecting the top 25 collaborators of Jiachang Chi. A scholar is included among the top collaborators of Jiachang Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiachang Chi. Jiachang Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 254 | |
| 7 | 1 | |
| 8 | 11 | |
| 9 | 4 | |
| 10 | 23 | |
| 11 | 23 | |
| 12 | 20 | |
| 13 | 21 | |
| 14 | 14 | |
| 15 | 28 | |
| 16 | 19 | |
| 17 | 46 | |
| 18 | 13 | |
| 19 | 15 | |
| 20 | 20 |
About Jiachang Chi
Jiachang Chi is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 943 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Hepatology (277 citations), Oncology (357 citations) and Immunology (182 citations). Jiachang Chi has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Bo Zhai, Yao Shi, Xingxing Qi, Xiaoyin Tang, Donghua Shi, Dan Cui, Huiping Gao, Huamao Wang, Hua Jiang and Zonghai Li. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.